title: PCCR: Pancreatic Cancer Collaborative Registry.
abstract: The Pancreatic Cancer Collaborative Registry (PCCR) is a multi-institutional web-based system aimed to collect a variety of data on pancreatic cancer patients and high-risk subjects in a standard and efficient way. The PCCR was initiated by a group of experts in medical oncology, gastroenterology, genetics, pathology, epidemiology, nutrition, and computer science with the goal of facilitating rapid and uniform collection of critical information and biological samples to be used in developing diagnostic, prevention and treatment strategies against pancreatic cancer. The PCCR is a multi-tier web application that utilizes Java/JSP technology and has Oracle 10 g database as a back-end. The PCCR uses a "confederation model" that encourages participation of any interested center, irrespective of its size or location. The PCCR utilizes a standardized approach to data collection and reporting, and uses extensive validation procedures to prevent entering erroneous data. The PCCR controlled vocabulary is harmonized with the NCI Thesaurus (NCIt) or Systematized Nomenclature of Medicine-Clinical Terms (SNOMED-CT). The PCCR questionnaire has accommodated standards accepted in cancer research and healthcare. Currently, seven cancer centers in the USA, as well as one center in Italy are participating in the PCCR. At present, the PCCR database contains data on more than 2,700 subjects (PC patients and individuals at high risk of getting this disease). The PCCR has been certified by the NCI Center for Biomedical Informatics and Information Technology as a cancer Biomedical Informatics Grid (caBIG(®)) Bronze Compatible product. The PCCR provides a foundation for collaborative PC research. It has all the necessary prerequisites for subsequent evolution of the developed infrastructure from simply gathering PC-related data into a biomedical computing platform vital for successful PC studies, care and treatment. Studies utilizing data collected in the PCCR may engender new approaches to disease prognosis, risk factor assessment, and therapeutic interventions.
authors.affiliation: Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: Simon
authors.initials: S
authors.lastname: Sherman
authors.forename: Oleg
authors.initials: O
authors.lastname: Shats
authors.forename: Marsha A
authors.initials: MA
authors.lastname: Ketcham
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Anderson
authors.forename: David C
authors.initials: DC
authors.lastname: Whitcomb
authors.forename: Henry T
authors.initials: HT
authors.lastname: Lynch
authors.forename: Paola
authors.initials: P
authors.lastname: Ghiorzo
authors.forename: Wendy S
authors.initials: WS
authors.lastname: Rubinstein
authors.forename: Aaron R
authors.initials: AR
authors.lastname: Sasson
authors.forename: William E
authors.initials: WE
authors.lastname: Grizzle
authors.forename: Gleb
authors.initials: G
authors.lastname: Haynatzki
authors.forename: Jianmin
authors.initials: J
authors.lastname: Feng
authors.forename: Alexander
authors.initials: A
authors.lastname: Sherman
authors.forename: Leo
authors.initials: L
authors.lastname: Kinarsky
authors.forename: Randall E
authors.initials: RE
authors.lastname: Brand